Premium Information is available for this item - Upgrade for $1 a day
6505-01-202-8882
Usp Glycopyrrolate Injection
6505012028882 012028882 NDC00469-3400-00
INC: 34122 Glycopyrrolate Injection
January 2023
6
Marketplace 6505-01-202-8882
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-202-8882 5+ Documents (More...)
NE Updated Every Usp Glycopyrrolate Usp Glycopyrrolate Injection 6505012028882 us 6505-01-202-8882 Usp
Usp Glycopyrrolate Injection 6505012028882 Glycopyrrolate Injection 6505012028882 RQST NE Updated
Usp Glycopyrrolate Injection 6505012028882 Usp Glycopyrrolate Injection 6505999683814 //www.nsnlookup.com
/fsg-65/fsc-6505/uk 6505-99 https 6505/us 6505-01-202-8882 Usp Glycopyrrolate Injection 6505012028882
6505991477498 Usp fsg-65/fsc-6505/us 6505-01-499-7214 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-202-8882
Usp Glycopyrrolate Injection 6505012028882 Injection 6505999683814 fsc-6505/ us 6505-01-202-8882
Usp Glycopyrrolate Injection 6505012028882 Glycopyrrolate Injection 6505012028882 RQST NE Updated
Usp Glycopyrrolate Injection 6505012028882 202-8882 Usp Glycopyrrolate Injection https https https
Glycopyrrolate Injection 6505010618187 Usp Glycopyrrolate Injection 6505999683814 fsc-6505/ us 6505-01-202-8882
Restrictions 6505-01-202-8882
6505-01-202-8882 is a Usp Glycopyrrolate Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item has been determined to be hazardous and information is contained in the Hazardous Materials Information Resource System (HMIRS). The precious metals content of this item is unknown.
Import and Export 6505-01-202-8882
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-202-8882
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-202-8882
- Part Number
- Manufacturer
- Status
- NDC00469-3400-00
- Manufacturer
- 60567 - Lyphomed Inc Div Of Fujisawa Usa Inc (Obsolete)
- Primary Buy
- Primary Buy
Datasheet 6505-01-202-8882
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Active Medicament Medicinal Strength [AKJA]
- 0.200 Milligrams Glycopyrrolate Per Milliliter
- Administration [CSGS]
- Intravenous Or Intramuscular
- Primary Container Type [CQCT]
- Fliptop Single Dose Vial
- Primary Container Content Quantity [CRLK]
- 1.000 Milliliters
- Pharmaceutical Vehicle Type [AKJQ]
- Hydroalcoholic
- Total Primary Container Quantity [CSCW]
- 25
- Supplementary Features [SUPP]
- 2 Ml Partial Fill Vial
Management Data 6505-01-202-8882
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Mar 1985
- Veterans Administration (VA)
- VI
- Subscribe
- VI
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains .001 Li
- 30000000001LI
- K
Similar Supply Items to 6505-01-202-8882
Freight Information 6505-01-202-8882
6505-01-202-8882 has freight characteristics.. 6505-01-202-8882 has a variance between NMFC and UFC when transported by rail and the description should be consulted.